Mice were challenged with 100 PFU of CCHFV strain IbAr 10200 or Afg09-2990 by the subcutaneous (IFNAR−/−) or intraperitoneal (all other mice) route, as indicated. Virus was diluted in a total volume of 0.2 ml of PBS (Gibco). All mice except IFNAR−/− were intraperitoneally injected with 2.5 mg of anti-IFNAR 1 (mAb-5A3; Leinco Technologies Inc.) diluted in PBS 24 hours after infection in a total volume of 0.4 ml. For antibody injections, as indicated, mice were injected subcutaneously or intraperitoneally with 1 mg per antibody per dose in a total volume of 0.2 ml diluted in PBS.

注意:以上内容是从某篇研究文章中自动提取的,可能无法正确显示。



Q&A
请登录并在线提交您的问题
您的问题将发布在Bio-101网站上。我们会将您的问题发送给本研究方案的作者和具有相关研究经验的Bio-protocol成员。我们将通过您的Bio-protocol帐户绑定邮箱进行消息通知。